Cabaletta Bio, Inc. — Director's Dealing 2024

Mar 4, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2024-03-01

Reporting Person: Marda Anup (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-01	Stock Option (Right to Buy)	$23.97	A	130000	Acquired	2034-02-28	Common Stock (130000)	Direct

Footnotes

F1: 25% of the shares underlying this option shall vest and become exercisable on March 1, 2025, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date.